These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 26530274

  • 1. Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma.
    Liu X, Qi D, Qi J, Mao Z, Li X, Zhang J, Li J, Gao W.
    Oncol Rep; 2016 Jan; 35(1):155-62. PubMed ID: 26530274
    [Abstract] [Full Text] [Related]

  • 2. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Sun J, Bi F, Yang Y, Zhang Y, Jin A, Li J, Lin Z.
    Oncol Rep; 2017 Feb; 37(2):857-864. PubMed ID: 27959420
    [Abstract] [Full Text] [Related]

  • 3. High expression of oncoprotein DEK predicts poor prognosis of small cell lung cancer.
    Wang X, Lin L, Ren X, Lin Z, Li Z, Li C, Jin T.
    Int J Clin Exp Pathol; 2014 Feb; 7(8):5016-23. PubMed ID: 25197373
    [Abstract] [Full Text] [Related]

  • 4. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
    Wang WP, Yan XL, Li WM, Ni YF, Zhao JB, Lu Q, Wang XJ, Sun Y, Chen P, Yan BY, Cui Y, Zhang ZP, Li XF.
    Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
    [Abstract] [Full Text] [Related]

  • 5. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
    Li Z, Zhang Y, Jin T, Men J, Lin Z, Qi P, Piao Y, Yan G.
    BMC Cancer; 2015 Mar 31; 15():207. PubMed ID: 25880877
    [Abstract] [Full Text] [Related]

  • 6. Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer.
    Kong F, Gao F, Chen J, Sun Y, Zhang Y, Liu H, Li X, Yang P, Zheng R, Liu G, Jia Y.
    Oncotarget; 2016 Aug 30; 7(35):56193-56199. PubMed ID: 27486880
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of DEK gene is correlated with poor prognosis in hepatocellular carcinoma.
    Yi HC, Liu YL, You P, Pan JS, Zhou JY, Liu ZJ, Zhang ZY.
    Mol Med Rep; 2015 Feb 30; 11(2):1318-23. PubMed ID: 25351213
    [Abstract] [Full Text] [Related]

  • 8. DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.
    Lin L, Piao J, Gao W, Piao Y, Jin G, Ma Y, Li J, Lin Z.
    BMC Cancer; 2013 Jul 31; 13():366. PubMed ID: 23902796
    [Abstract] [Full Text] [Related]

  • 9. The miR-1204 regulates apoptosis in NSCLC cells by targeting DEK.
    Qian Z, Yang J, Liu H, Yin Y, Hou L, Hu H.
    Folia Histochem Cytobiol; 2019 Jul 31; 57(2):64-73. PubMed ID: 31246264
    [Abstract] [Full Text] [Related]

  • 10. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.
    Zhang D, Jin X, Wang F, Wang S, Deng C, Gao Z, Guo C.
    Ann Surg Oncol; 2007 Dec 31; 14(12):3581-92. PubMed ID: 17899287
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
    Ghasemkhani N, Shadvar S, Masoudi Y, Talaei AJ, Yahaghi E, Goudarzi PK, Shakiba E.
    Diagn Pathol; 2015 Sep 17; 10():164. PubMed ID: 26377406
    [Abstract] [Full Text] [Related]

  • 13. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
    Yang H, Gao XY, Li P, Jiang TS.
    Tumour Biol; 2015 Mar 17; 36(3):2179-84. PubMed ID: 25412952
    [Abstract] [Full Text] [Related]

  • 14. NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer.
    Cui X, Jin T, Wang X, Jin G, Li Z, Lin L.
    Oncol Rep; 2014 Dec 17; 32(6):2589-95. PubMed ID: 25231218
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The clinical significance of transforming acidic coiled-coil protein 3 expression in non-small cell lung cancer.
    Jiang F, Kuang B, Que Y, Lin Z, Yuan L, Xiao W, Peng R, Zhang X, Zhang X.
    Oncol Rep; 2016 Jan 17; 35(1):436-46. PubMed ID: 26531241
    [Abstract] [Full Text] [Related]

  • 17. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
    Bai Y, Wang YL, Yao WJ, Guo L, Xi HF, Li SY, Zhao BS.
    Int J Clin Exp Pathol; 2015 Jan 17; 8(1):824-9. PubMed ID: 25755781
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Down-regulation of PAX6 by promoter methylation is associated with poor prognosis in non small cell lung cancer.
    Zhang X, Yang X, Wang J, Liang T, Gu Y, Yang D.
    Int J Clin Exp Pathol; 2015 Jan 17; 8(9):11452-7. PubMed ID: 26617874
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.